Retinal vessel changes in galactose-fed dogs

Archives of Ophthalmology

Volumn 116, Issue 6, 1998, Pages 785-789

  Kobayashi, Tatsuji ^a   Kubo, Eri ^a   Takahashi, Yukio ^a   Kasahara, Toshiharu ^b   Yonezawa, Hidetoshi ^b   Akagi, Yoshio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE;

ANIMAL MODEL; ARTICLE; CAMERA; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOG; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL;

EID: 0031866974     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.6.785     Document Type: Article

References (16)

1. Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1984;33:97-100.
2. Takahashi Y, Wyman M, Ferris F, Kador PF. Diabeteslike preproliferative retinal changes in galactose-fed dogs. Arch Ophthalmol. 1992;110:1295-1302.
3. Kador PF, Takahashi Y, Wyman M, Ferris F III. Diabeteslike proliferate retinal changes in galactose-fed dogs. Arch Ophthalmol. 1995;113:352-354.
4. Kador PF, Akagi Y, Terubayashi H, Wyman M, Kinoshita JH. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1988;106:1099-1102.
5. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1990;108:1301-1309
6. Takahashi Y, Augustin W, Wyman M, Kador PF. Quantitative analysis of retinal vessel changes in galactose-fed dogs. Ocular Pharmacol. 1993;9:257-269.
7. Sato S, Takahashi Y, Wymann M, Kador PF. Progression of sugar cataract in galactose-fed dogs. Invest Ophthalmol Vis Sci. 1991;32:1925-1931.
8. Engerman RL, Bloodworth JMB Jr. Experimental diabetic retinopathy in dogs. Arch Ophthalmol. 1965;73:205-210.
9. Robison WG Jr. Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci. 1989;30:2285-2292.
10. Engerman RL, Kern TS. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes. 1993;42:820-825.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329: 977-987.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the progression of diabetic retinopathy in insulindependent diabetes mellitus. Arch Ophthalmol. 1995;113:36-51.
13. Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns, IV: diabetic retinopathy. Arch Ophthalmol. 1961;66:366-378.
14. Cogan DG, Kuwabara T. Capillary shunts in the pathogenesis of diabetic retinopathy. Diabetes. 1963;12:293-300.
15. Cogan DG, Kuwabara T The mural cell in perspective. Arch Ophthalmol. 1967; 78:133-139.
16. Kador PF. The role of aldose reductase in the development of diabetic complications. Med Res Rev. 1988;8:325-352.